Literature DB >> 9736021

Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor).

C Li1, B Bapat, B A Alman.   

Abstract

Aggressive fibromatosis is a monoclonal proliferation of spindle (fibroblast-like) cells. A subset of lesions contain somatic truncating adenomatous polyposis coli (APC) gene mutations, and all of the lesions contain an elevated beta-catenin protein level. A major function of APC is to regulate beta-catenin protein level. Beta-catenin has a dual function in the cell: it is a member of the adherens junction, and it binds transcription factors in the tcf-lef family, transactivating transcription. Cell cultures from aggressive fibromatoses containing an APC mutation were studied. Transient transfection of the full-length APC gene caused decreased proliferation and beta-catenin protein level in these cultures. To determine whether beta-catenin protein level was responsible for the change in proliferation rate, stable transfections of deltaN89beta-catenin (a stabilized form that is not degraded by APC, but retains all other functions) were achieved in half of the cultures derived from each tumor, whereas the other half were transfected with an empty vector. Transfection of the full-length APC gene in cultures that were stably transfected with deltaN89beta-catenin did not result in a change in proliferation. The type I promotor of p56lck contains an HMG consensus region, to which members of the tcf-lef family can bind. p56lck was expressed in cultures not transfected with the full-length APC gene and in cultures transfected with the full-length APC gene and deltaN89beta-catenin, but not in cultures transfected with only the full-length APC gene. These data show that APC truncating mutations give aggressive fibromatosis cells a proliferative advantage through beta-catenin and suggest that beta-catenin acts to transactivate transcription.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736021      PMCID: PMC1853030          DOI: 10.1016/s0002-9440(10)65614-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

1.  In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states.

Authors:  B Ansari; P J Coates; B D Greenstein; P A Hall
Journal:  J Pathol       Date:  1993-05       Impact factor: 7.996

2.  An alternative pathway for expression of p56lck from type I promoter transcripts in colon carcinoma.

Authors:  S McCracken; C S Kim; Y Xu; M Minden; N G Miyamoto
Journal:  Oncogene       Date:  1997-12-11       Impact factor: 9.867

3.  Identification of FAP locus genes from chromosome 5q21.

Authors:  K W Kinzler; M C Nilbert; L K Su; B Vogelstein; T M Bryan; D B Levy; K J Smith; A C Preisinger; P Hedge; D McKechnie
Journal:  Science       Date:  1991-08-09       Impact factor: 47.728

4.  Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activation.

Authors:  A Veillette; I D Horak; E M Horak; M A Bookman; J B Bolen
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

5.  Expression of the lck tyrosine kinase gene in human colon carcinoma and other non-lymphoid human tumor cell lines.

Authors:  A Veillette; F M Foss; E A Sausville; J B Bolen; N Rosen
Journal:  Oncogene Res       Date:  1987 Sep-Oct

6.  Structural basis for DNA bending by the architectural transcription factor LEF-1.

Authors:  J J Love; X Li; D A Case; K Giese; R Grosschedl; P E Wright
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

7.  Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.

Authors:  B Rubinfeld; I Albert; E Porfiri; C Fiol; S Munemitsu; P Polakis
Journal:  Science       Date:  1996-05-17       Impact factor: 47.728

8.  An aberrant lck mRNA in two human T-cell lines.

Authors:  L B Vogel; R Arthur; D J Fujita
Journal:  Biochim Biophys Acta       Date:  1995-11-07

9.  Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box.

Authors:  M van de Wetering; M Oosterwegel; D Dooijes; H Clevers
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

10.  APC mutation analysis by chemical cleavage of mismatch and a protein truncation assay in familial adenomatous polyposis.

Authors:  J Prosser; A Condie; M Wright; J M Horn; J A Fantes; A H Wyllie; M G Dunlop
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

View more
  23 in total

1.  Abdominal pain and colonic obstruction from an intra-abdominal desmoid tumor.

Authors:  Deepak Venkat; Edward Levine; William E Wise
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-10

2.  Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.

Authors:  Aimee M Crago; Juliann Chmielecki; Mara Rosenberg; Rachael O'Connor; Caitlin Byrne; Fatima G Wilder; Katherine Thorn; Phaedra Agius; Deborah Kuk; Nicholas D Socci; Li-Xuan Qin; Matthew Meyerson; Meera Hameed; Samuel Singer
Journal:  Genes Chromosomes Cancer       Date:  2015-07-14       Impact factor: 5.006

3.  beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds.

Authors:  Sophia S Cheon; Alexander Y L Cheah; Stefanie Turley; Puviindran Nadesan; Raymond Poon; Hans Clevers; Benjamin A Alman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 4.  The Wnt signaling pathway and its role in tumor development.

Authors:  B Lustig; J Behrens
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-18       Impact factor: 4.553

5.  A prognostic nomogram for prediction of recurrence in desmoid fibromatosis.

Authors:  Aimeé M Crago; Brian Denton; Sébastien Salas; Armelle Dufresne; James J Mezhir; Meera Hameed; Mithat Gonen; Samuel Singer; Murray F Brennan
Journal:  Ann Surg       Date:  2013-08       Impact factor: 12.969

6.  Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis.

Authors:  Umio Yamaguchi; Tadashi Hasegawa; Taizo Masuda; Shigeki Sekine; Akira Kawai; Hirokazu Chuman; Tadakazu Shimoda
Journal:  Virchows Arch       Date:  2004-06-30       Impact factor: 4.064

7.  Beta-catenin is a mediator of the response of fibroblasts to irradiation.

Authors:  Ananta Gurung; Faisal Uddin; Richard P Hill; Peter C Ferguson; Benjamin A Alman
Journal:  Am J Pathol       Date:  2008-11-26       Impact factor: 4.307

8.  Mesenchymal Tumors Can Derive from Ng2/Cspg4-Expressing Pericytes with β-Catenin Modulating the Neoplastic Phenotype.

Authors:  Shingo Sato; Yuning J Tang; Qingxia Wei; Makoto Hirata; Angela Weng; Ilkyu Han; Atsushi Okawa; Shu Takeda; Heather Whetstone; Puvindran Nadesan; David G Kirsch; Jay S Wunder; Benjamin A Alman
Journal:  Cell Rep       Date:  2016-07-14       Impact factor: 9.423

Review 9.  Targeted therapies: the rare cancer paradigm.

Authors:  Marco A Pierotti; Tiziana Negri; Elena Tamborini; Federica Perrone; Sabrina Pricl; Silvana Pilotti
Journal:  Mol Oncol       Date:  2009-10-28       Impact factor: 6.603

10.  Beta-catenin and transforming growth factor beta have distinct roles regulating fibroblast cell motility and the induction of collagen lattice contraction.

Authors:  Raymond Poon; Saeid Amini Nik; Jessica Ahn; Laura Slade; Benjamin A Alman
Journal:  BMC Cell Biol       Date:  2009-05-11       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.